NeoGenomics, Inc. Sales Revenue, Services, Other (Deprecated 2018-01-31)
NeoGenomics, Inc. (NEO) reported Sales Revenue, Services, Other (Deprecated 2018-01-31) of $360.17 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueServicesGross · last filed 2018-03-13
- NeoGenomics, Inc. sales revenue, services, other (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $96.94M, a 17.01% decline year-over-year.
- NeoGenomics, Inc. sales revenue, services, other (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $85.43M, a 25.65% decline year-over-year.
- NeoGenomics, Inc. sales revenue, services, other (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $93.86M, a 27.37% decline year-over-year.
- NeoGenomics, Inc. sales revenue, services, other (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $83.94M, a 36.76% decline year-over-year.
- NeoGenomics, Inc. sales revenue, services, other (deprecated 2018-01-31) for fiscal 2017 was $360.17M, a 27.04% decline from fiscal 2016.
- NeoGenomics, Inc. sales revenue, services, other (deprecated 2018-01-31) for fiscal 2016 was $493.68M, a 119.36% increase from fiscal 2015.
- NeoGenomics, Inc. sales revenue, services, other (deprecated 2018-01-31) for fiscal 2015 was $225.06M, a 0.27% increase from fiscal 2014.
- NeoGenomics, Inc. sales revenue, services, other (deprecated 2018-01-31) for fiscal 2014 was $224.46M, a 29.16% increase from fiscal 2013.
| Period end | Sales Revenue, Services, Other (Deprecated 2018-01-31) 3 month | Sales Revenue, Services, Other (Deprecated 2018-01-31) 6 month | Sales Revenue, Services, Other (Deprecated 2018-01-31) 9 month | Sales Revenue, Services, Other (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2017-12-31 | $96.94M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $182.37M derived: sum of 2 quarters · filed 2018-03-13 | $276.24M derived: sum of 3 quarters · filed 2018-03-13 | $360.17M 10-K · filed 2018-03-13 |
| 2017-09-30 | $85.43M 10-Q · filed 2017-11-13 | $179.29M derived: sum of 2 quarters · filed 2017-11-13 | $263.23M 10-Q · filed 2017-11-13 | $380.05M derived: sum of 4 quarters · filed 2018-03-13 |
| 2017-06-30 | $93.86M 10-Q · filed 2017-08-07 | $177.80M 10-Q · filed 2017-08-07 | $294.62M derived: sum of 3 quarters · filed 2018-03-13 | $409.52M derived: sum of 4 quarters · filed 2018-03-13 |
| 2017-03-31 | $83.94M 10-Q · filed 2017-05-09 | $200.76M derived: sum of 2 quarters · filed 2018-03-13 | $315.66M derived: sum of 3 quarters · filed 2018-03-13 | $444.90M derived: sum of 4 quarters · filed 2018-03-13 |
| 2016-12-31 | $116.82M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $231.72M derived: sum of 2 quarters · filed 2018-03-13 | $360.96M derived: sum of 3 quarters · filed 2018-03-13 | $493.68M 10-K · filed 2018-03-13 |
| 2016-09-30 | $114.90M 10-Q · filed 2017-11-13 | $244.14M derived: sum of 2 quarters · filed 2017-11-13 | $376.86M 10-Q · filed 2017-11-13 | $434.39M derived: sum of 4 quarters · filed 2018-03-13 |
| 2016-06-30 | $129.24M 10-Q · filed 2017-08-07 | $261.95M 10-Q · filed 2017-08-07 | $319.49M derived: sum of 3 quarters · filed 2018-03-13 | $376.68M derived: sum of 4 quarters · filed 2018-03-13 |
| 2016-03-31 | $132.72M 10-Q · filed 2017-05-09 | $190.25M derived: sum of 2 quarters · filed 2018-03-13 | $247.44M derived: sum of 3 quarters · filed 2018-03-13 | $304.15M derived: sum of 4 quarters · filed 2018-03-13 |
| 2015-12-31 | $57.53M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $114.72M derived: sum of 2 quarters · filed 2018-03-13 | $171.43M derived: sum of 3 quarters · filed 2018-03-13 | $225.06M 10-K · filed 2018-03-13 |
| 2015-09-30 | $57.19M 10-Q · filed 2016-11-07 | $113.89M derived: sum of 2 quarters · filed 2016-11-07 | $167.53M 10-Q · filed 2016-11-07 | $232.32M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | $56.70M 10-Q · filed 2016-08-05 | $110.33M 10-Q · filed 2016-08-05 | $175.13M derived: sum of 3 quarters · filed 2017-03-14 | $235.79M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-03-31 | $53.63M 10-Q · filed 2016-05-10 | $118.43M derived: sum of 2 quarters · filed 2017-03-14 | $179.09M derived: sum of 3 quarters · filed 2017-03-14 | $236.89M derived: sum of 4 quarters · filed 2017-03-14 |
| 2014-12-31 | $64.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $125.45M derived: sum of 2 quarters · filed 2017-03-14 | $183.26M derived: sum of 3 quarters · filed 2017-03-14 | $224.46M 10-K · filed 2017-03-14 |
| 2014-09-30 | $60.66M 10-Q · filed 2015-11-06 | $118.47M derived: sum of 2 quarters · filed 2015-07-31 | $159.66M 10-Q · filed 2015-11-06 | $203.82M derived: sum of 4 quarters · filed 2016-04-18 |
| 2014-06-30 | $57.80M 10-Q · filed 2015-07-31 | $99.00M 10-Q · filed 2015-07-31 | $143.16M derived: sum of 3 quarters · filed 2016-04-18 | $188.32M derived: sum of 4 quarters · filed 2016-04-18 |
| 2014-03-31 | $41.20M 10-Q · filed 2015-05-11 | $85.36M derived: sum of 2 quarters · filed 2016-04-18 | $130.52M derived: sum of 3 quarters · filed 2016-04-18 | $173.66M derived: sum of 4 quarters · filed 2016-04-18 |
| 2013-12-31 | $44.16M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-18 | $89.32M derived: sum of 2 quarters · filed 2016-04-18 | $132.46M derived: sum of 3 quarters · filed 2016-04-18 | $173.78M 10-K · filed 2016-04-18 |
| 2013-09-30 | $45.16M 10-Q · filed 2014-11-04 | $88.30M derived: sum of 2 quarters · filed 2014-11-04 | $129.63M 10-Q · filed 2014-11-04 | $169.09M derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-06-30 | $43.14M 10-Q · filed 2014-07-29 | $84.47M 10-Q · filed 2014-07-29 | $123.93M derived: sum of 3 quarters · filed 2015-03-03 | $158.73M derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-03-31 | $41.33M 10-Q · filed 2014-05-12 | $80.78M derived: sum of 2 quarters · filed 2015-03-03 | $115.59M derived: sum of 3 quarters · filed 2015-03-03 | |
| 2012-12-31 | $39.46M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $74.27M derived: sum of 2 quarters · filed 2015-03-03 | $157.59M 10-K · filed 2015-03-03 | |
| 2012-09-30 | $34.81M 10-Q · filed 2013-10-30 | $118.13M 10-Q · filed 2013-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |